Form 4: Biogen Executive Kramer Reports Stock Transactions

Robin Kramer, Chief Accounting Officer of Biogen, reports the vesting of restricted stock units and subsequent tax withholding.

Summary

• On February 10, 2025, Robin Kramer, Chief Accounting Officer of Biogen, reported transactions involving Biogen's common stock.
• Kramer vested 834 restricted stock units (RSUs) which converted into common stock.
• Simultaneously, 245 shares were disposed of to cover tax obligations at a price of $142.54 per share.
• Following these transactions, Kramer directly owns 8,011.7483 shares of Biogen common stock.
• The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, and does not inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common practice in publicly traded companies. It provides transparency into the executive's holdings and transactions in the company's stock.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect routine executive compensation and tax-related stock disposals.

Key Dates

Keywords

Biogen, BIIB, Form 4, Robin Kramer, Restricted Stock Units, RSU, Beneficial Ownership, Chief Accounting Officer, Stock Transaction